MINICA-S

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
MINICA-S
Generic name
GLYCERIN
Manufacturer
Sato Pharmaceutical Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
687902eb-e702-4e87-a0ce-9add05e3cbc1
SPL ID
54680539-3343-d78c-e063-6294a90aa416
Version
9
Effective date
2026-06-16
Source export date
2026-11-06
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/8ec9b1418c25a8bb472a36e6bc0b2cbabb210d48d5dd734197e022d21529ed58/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
Import run
20261106T075659Z
Imported at
2026-11-06 09:17:11
Harmonized routes table
Harmonized routes
RECTAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For rectal use only Do not use ■for a period of longer than 1 week unless directed by a doctor. Frequent or prolonged use of this preparation may result in dependence on laxatives. Ask a doctor before use if you have ■abdominal pain, nausea, or vomiting. ■noticed a sudden change in bowel habits that persists over a period of 2 weeks. When using this product ■may cause rectal discomfort or burning sensation. Stop use and ask a doctor if ■you have rectal bleeding or failure to have a bowel movement after use of a laxative. This may indicate a serious condition. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.